In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N-Methyl-D-Glucamine Drug Master File in Korea (N-Methyl-D-Glucamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N-Methyl-D-Glucamine. The MFDS reviews the N-Methyl-D-Glucamine KDMF as part of the drug registration process and uses the information provided in the N-Methyl-D-Glucamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a N-Methyl-D-Glucamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N-Methyl-D-Glucamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N-Methyl-D-Glucamine suppliers with KDMF on PharmaCompass.